Prime Medicine (PRME) Equity Ratio (2021 - 2026)

Prime Medicine posted quarterly Equity Ratio of 0.26 for Q1 2026, down 20.13% year-on-year from 0.33 in Q1 2025, and down 26.21% on a QoQ basis from 0.35 in Q4 2025.

Prime Medicine (PRME) has 6 years of Equity Ratio data on file, last reported at 0.26 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 20.13% year-over-year to 0.26; the trailing twelve-month figure through Mar 2026 stood at 0.26 (down 20.13% YoY), and the FY2025 full-year result was 0.35, down 31.49% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.26, down from 0.35 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.88 in Q1 2023 and bottomed at 1.04 in Q3 2022.
  • The 5-year median for Equity Ratio is 0.57 (2024), against an average of 0.48.
  • The widest annual swing landed in 2022, when Equity Ratio soared 269.58%; it then slumped 71.18% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.88 in 2022, then retreated by 21.79% to 0.69 in 2023, then declined by 25.01% to 0.51 in 2024, then tumbled by 31.49% to 0.35 in 2025, then dropped by 26.21% to 0.26 in 2026.
  • The last three Equity Ratio figures came in at 0.26 (Q1 2026), 0.35 (Q4 2025), and 0.42 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Prime Medicine 601.24 Mn 601.24 Mn - 0.26

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.26
Dec 31, 2025 0.35
Sep 30, 2025 0.42
Jun 30, 2025 0.22
Mar 31, 2025 0.33
Dec 31, 2024 0.51
Sep 30, 2024 0.57
Jun 30, 2024 0.76
Mar 31, 2024 0.78
Dec 31, 2023 0.69
Sep 30, 2023 0.81
Jun 30, 2023 0.85
Mar 31, 2023 0.88
Dec 31, 2022 0.88
Sep 30, 2022 -1.04
Dec 31, 2021 -0.52